Cystic Fibrosis (CF) Clinical Trials in Little Rock, Arkansas

3 studies are recruiting for cystic fibrosis (cf) in Little Rock, Arkansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

    The purpose of this study is to measure the safety and explore the efficacy of 4 different doses of the new lipase NHS7108 in participants with EPI. In this study, all participants will take NHS7108 daily for 14 days and a matching dose of standard-of-care, pancrelipase (Zenpep®) for 14 days accord…

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    University of Arkansas for Medical Sciences Hospital - University, Little Rock, Arkansas
    Locations
    39 in total
    Run by
    Aimmune Nestlé Health Science US R&D, LLC

    See if you can join NCT07559175 on ClinicalTrials.gov

  2. Ensuring Access to Optimal Therapy in CF: The ENACT Study

    This clinical trial is examining the action and effects of several new drugs in the treatment of cystic fibrosis in children. In addition, several genetic factors are examined. The hope is that the ability to determine prior to treatment those individuals who will or will not respond to existing th…

    Stage
    Phase 4
    Ages
    3 and older
    Site
    Arkansas Children's Hospital, Little Rock, Arkansas
    Locations
    3 in total
    Run by
    Arkansas Children's Hospital Research Institute

    See if you can join NCT07148739 on ClinicalTrials.gov

  3. Study With Phage for CF Subjects With Pseudomonas Lung Infection

    The goal of this Phase 2b clinical trial is to see if nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa (PsA) lung infection in CF subjects. The primary goal is to see if 8 weeks of twice daily BX004 can reduce the amount of PsA in the sputum compared to placebo (on top of background…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Arkansas for Medical Sciences, Little Rock, Arkansas
    Locations
    14 in total
    Run by
    BiomX Ltd

    See if you can join NCT06998043 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.